Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer

被引:34
|
作者
Maruyama, Reo [1 ]
Suzuki, Hiromu [1 ]
Yamamoto, Eiichiro [2 ]
Imai, Kohzoh [3 ]
Shinomura, Yasuhisa [2 ]
机构
[1] Sapporo Med Univ, Dept Mol Biol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan
[2] Sapporo Med Univ, Dept Internal Med 1, Sapporo, Hokkaido 0608556, Japan
[3] Univ Tokyo, Inst Med Sci, Div Novel Therapy Canc, Adv Clin Res Ctr, Tokyo, Japan
关键词
Noncoding RNA; MicroRNA; lincRNA; DNA methylation; Histone modification; ACUTE LYMPHOBLASTIC-LEUKEMIA; TUMOR-SUPPRESSIVE MICRORNAS; CPG ISLAND METHYLATION; COLORECTAL-CANCER; DNA HYPERMETHYLATION; DOWN-REGULATION; GASTRIC-CANCER; BREAST-CANCER; CELL CARCINOMA; FIELD DEFECT;
D O I
10.1007/s13277-011-0308-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epigenetic changes, including DNA methylation and histone modification, play key roles in the dysregulation of tumor-related genes, thereby affecting numerous cellular processes, including cell proliferation, cell adhesion, apoptosis, and metastasis. In recent years, numerous studies have shown that noncoding RNAs (ncRNAs) are key players in the initiation and progression of cancer and epigenetic mechanisms are deeply involved in their dysregulation. Indeed, the growing list of microRNA (miRNA) genes aberrantly methylated in cancer suggests that a large number of miRNAs exert tumor-suppressive or oncogenic effects. In addition, it now appears that long ncRNAs may be causally related to epigenetic dysregulation of critical genes in cancer. Dissection of the relationships between ncRNAs and epigenetic alterations may lead to the development of novel approaches to the diagnosis and treatment of cancer.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 50 条
  • [41] Crosstalk between oncogenic MYC and noncoding RNAs in cancer
    Tu, Rongfu
    Chen, Zhi
    Bao, Qing
    Liu, Hudan
    Qing, Guoliang
    SEMINARS IN CANCER BIOLOGY, 2021, 75 : 62 - 71
  • [42] Intricate crosstalk between MYB and noncoding RNAs in cancer
    Dingyu Hu
    Wenjun Shao
    Li Liu
    Yanyan Wang
    Shunling Yuan
    Zhaoping Liu
    Jing Liu
    Ji Zhang
    Cancer Cell International, 21
  • [43] Intricate crosstalk between MYB and noncoding RNAs in cancer
    Hu, Dingyu
    Shao, Wenjun
    Liu, Li
    Wang, Yanyan
    Yuan, Shunling
    Liu, Zhaoping
    Liu, Jing
    Zhang, Ji
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [44] Epigenetic Dysregulation in Cancer
    Muntean, Andrew G.
    Hess, Jay L.
    AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (04): : 1353 - 1361
  • [45] Noncoding RNAs and DNA methylation alterations as liquid biopsy biomarkers in colorectal cancer
    Goel, Ajay
    CANCER RESEARCH, 2022, 82 (23) : 11 - 11
  • [46] Emerging biology of noncoding RNAs in malaria parasites
    Simantov, Karina
    Goyal, Manish
    Dzikowski, Ron
    PLOS PATHOGENS, 2022, 18 (07)
  • [47] Noncoding RNAs: Emerging Players in Muscular Dystrophies
    Falcone, Germana
    Perfetti, Alessandra
    Cardinali, Beatrice
    Martelli, Fabio
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [48] Emerging roles of noncoding RNAs in human cancers
    Wu, Shijie
    Wu, Yiwen
    Deng, Sijun
    Lei, Xiaoyong
    Yang, Xiaoyan
    DISCOVER ONCOLOGY, 2023, 14 (01)
  • [49] Long Noncoding RNAs: Emerging Players in Medulloblastoma
    Laneve, Pietro
    Rea, Jessica
    Caffarelli, Elisa
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [50] Noncoding RNAs: Emerging regulators of behavioral complexity
    Dayal, Sanovar
    Chaubey, Divya
    Joshi, Dheeraj Chandra
    Ranmale, Samruddhi
    Pillai, Beena
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2024, 15 (03)